4CMenB vaccine is effective against invasive meningococcal disease in children under 5 years of age
A complete vaccine with four components, the protein-based meningococcal serogroup B vaccine (4CMenB) is effective in preventing invasive meningococcal disease in children younger than 5 years of age, according to a study published in the Feb. 2 issue of New England Journal of Medicine. Jesus Castilla, MD, Ph.D., from the Instituto de Salud Pública de … Read more